Ethical issues arising from commercial sponsorship and from relationships with the pharmaceutical industry

  Just published in Cephalalgia [subscription required]:

Steiner TJ. Ethical issues arising from commercial sponsorship and from relationships with the pharmaceutical industry–Report and Recommendations of the Ethics Subcommittee of the International Headache Society. Cephalalgia. 2008 Sep;28 Suppl 3:1-25.
Preface: These recommendations, the second set developed for the International Headache Society (IHS) by its Ethics Subcommittee, evolved over 3 years. This extended period allowed time for public consultation, an important part of the formulation process, and for consequent revision. The recommendations were presented in this final form to IHS Council in late 2005, and approved for publication in Cephalalgia. The delay from then until now would have been better avoided. The reasons for it, which did not lie with the Subcommittee, are not of current interest. What matters is that these recommendations remain entirely relevant to their purpose. In one area – the registration of clinical trials – matters have moved on in the interim. As the Subcommittee anticipated, registration of trials is becoming standard practice. This goal is not yet achieved, but laudable and largely voluntary initiatives by the pharmaceutical industry have brought about much recent progress. Clear international consensus has yet to emerge on what needs to be included in a clinical trials registry, and when. This does not help, since it is not entirely certain what the desired end is. But it seems likely that, with or without further regulation, this end will be both clear and in sight in not too long. Headache will benefit, along with all other fields of medicine.
Summary of recommendations
1.1 Conflicts of interests in relationships with commercial sponsors
1.2 Commercially sponsored research
1.3 Commercially sponsored clinical services
1.4 Commercially sponsored education
1.5 Marketing

%d bloggers like this: